Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects. JASRAE [Internet]. 2019 May 1 [cited 2026 Apr. 4];16(6):3589-95. Available from: https://ignited.in/index.php/jasrae/article/view/11970